144 related articles for article (PubMed ID: 8704098)
1. In vivo effects of interleukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in normal mice.
Jovcic G; Ivanovic Z; Biljanovic-Paunovic L; Bugarski D; Stosic-Grujicic S; Milenkovic P
Eur Cytokine Netw; 1996; 7(1):71-4. PubMed ID: 8704098
[TBL] [Abstract][Full Text] [Related]
2. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow.
Jovcić G; Ivanović Z; Biljanović-Paunović L; Bugarski D; Stosić-Grujicić S; Milenković P
Leukemia; 1996 Mar; 10(3):564-9. PubMed ID: 8642876
[TBL] [Abstract][Full Text] [Related]
3. The in vivo effect of recombinant human interleukin-1 receptor antagonist on spleen colony forming cells after radiation induced myelosuppression.
Milenkovíc P; Ivanovíc Z; Stosić-Grujicić S
Eur Cytokine Netw; 1995; 6(3):177-80. PubMed ID: 8589274
[TBL] [Abstract][Full Text] [Related]
4. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
[TBL] [Abstract][Full Text] [Related]
5. Effects of rhIL-1 alpha, rhIL-1 beta, and rhIL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow.
Aoki I; Homori M; Nakahara K; Higashi K; Ishikawa K
Exp Hematol; 1995 Mar; 23(3):217-25. PubMed ID: 7533099
[TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
7. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of human recombinant interleukin 6 on hemopoietic stem and progenitor cells and circulating blood cells in normal mice.
Pojda Z; Tsuboi A
Exp Hematol; 1990 Oct; 18(9):1034-7. PubMed ID: 2397750
[TBL] [Abstract][Full Text] [Related]
9. Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units-granulocyte, macrophage) after acute administration of recombinant human IL-1 alpha.
Pelus LM
J Immunol; 1989 Dec; 143(12):4171-9. PubMed ID: 2592770
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of natural killer cells on modulating CFU-Meg and BFU-E proliferation in situ.
Pantel K; Nakeff A
Exp Hematol; 1989 Nov; 17(10):1017-21. PubMed ID: 2806434
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
[TBL] [Abstract][Full Text] [Related]
12. [The effect of specific interleukin-1 receptor blockade on hematopoietic stem cell proliferation].
Stosić-Grujicić S; Milenković P; Ivanović Z; Lukić M
Srp Arh Celok Lek; 1994; 122 Suppl 1():13-4. PubMed ID: 18173175
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.
Kaushansky K; Lin N; Grossmann A; Humes J; Sprugel KH; Broudy VC
Exp Hematol; 1996 Feb; 24(2):265-9. PubMed ID: 8641351
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis.
Johnson CS; Braunschweiger PG; Furmanski P
In Vivo; 1990; 4(2):93-6. PubMed ID: 2129805
[TBL] [Abstract][Full Text] [Related]
15. The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones.
Blazsek I; Liu XH; Anjo A; Quittet P; Comisso M; Kim-Triana B; Misset JL
Exp Hematol; 1995 Apr; 23(4):309-19. PubMed ID: 7895780
[TBL] [Abstract][Full Text] [Related]
16. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of IL-17 and blockade of nitric oxide biosynthesis on haematopoiesis in mice.
Krstić A; Santibanez JF; Okić I; Mojsilović S; Kocić J; Jovcić G; Milenković P; Bugarski D
Acta Physiol (Oxf); 2010 May; 199(1):31-41. PubMed ID: 20102341
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse.
Zhang J; Xiang D; Zhu S; Mao W; Lu H; Wu M; Wang Q; Yu Y; Herbst KD; Han W
Biomed Pharmacother; 2009 Aug; 63(7):501-8. PubMed ID: 18980827
[TBL] [Abstract][Full Text] [Related]
19. Hematopoiesis during acute Toxoplasma gondii infection in mice.
Petakov M; Stojanović N; Jovcić G; Bugarski D; Todorović V; Djurković-Djaković O
Haematologia (Budap); 2002; 32(4):439-55. PubMed ID: 12803118
[TBL] [Abstract][Full Text] [Related]
20. [Preiliminary studies on the efficacy and mechanism of interleukin-3 in the treatment of myelosuppression in mice].
Chen J; Hu W; Zhao S; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 May; 13(2):134-7. PubMed ID: 10074234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
